- US-listed companies
- CONMED Corp
- Cash flow
CONMED Corp【CNMD】Cash flow
Market cap
$1.3B
P/E ratio
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Stock-based compensation | 5 | 6 | 6 | 9 | 7 | 8 | 8 | 10 | 12 | 13 | 16 | 22 | 24 | 26 |
| Cash from operations | 103 | 95 | 81 | 65 | 48 | 38 | 66 | 75 | 95 | 65 | 112 | 33 | 125 | 167 |
| Capital expenditures | -18 | -22 | -18 | -15 | -15 | -15 | -13 | -17 | -20 | -13 | -15 | -22 | -19 | -13 |
| Cash from investing | -22 | -106 | -18 | -21 | -24 | -266 | -29 | -17 | -388 | -14 | -15 | -250 | -20 | -13 |
| Repurchases of common stock | 15 | 4 | 51 | 17 | - | - | - | - | - | - | - | - | - | - |
| Proceeds from issuance of term debt, net | - | - | - | - | - | 175 | - | - | 265 | - | - | - | - | - |
| Repayments of term debt | - | - | - | - | - | 9 | 9 | 13 | 154 | - | - | - | - | - |
| Cash from financing | -67 | 11 | -31 | -26 | -10 | 184 | -35 | -72 | 301 | -52 | -102 | 225 | -110 | -151 |
| Free cash flow | ||||||||||||||
| FCF margin (%) |